Divested.
Indigo is developing an implantable sensor that allows to continuously measure glucose and other metabolites for up to two years.
QustomDot is developing cadmium-free quantum dots that are stable enough for advanced applications.
Axithra is developing new technology for accurate drug concentrations in blood.
